AL-78898A
- Generic Name
- AL-78898A
A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2014-01-20
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 10
- Registration Number
- NCT01603043
Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration
Phase 2
Completed
- Conditions
- Exudative Age-Related Macular Degeneration
- Interventions
- First Posted Date
- 2010-07-05
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 99
- Registration Number
- NCT01157065
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
Phase 1
Completed
- Conditions
- Age-Related Macular Degeneration
- First Posted Date
- 2007-05-16
- Last Posted Date
- 2010-03-18
- Lead Sponsor
- Potentia Pharmaceuticals, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT00473928
- Locations
- 🇺🇸
United States, Minnesota, Rochester, Minnesota, United States
🇺🇸United States, Florida, Miami, Florida, United States
🇺🇸United States, New Hampshire, Portsmouth, New Hampshire, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath